SCHEMBL4457515

SCHEMBL4457515

Nc1ccc2c(c1)CC(N1CCNCC1)C(=O)N2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.44
DRD4 P21917 1/20 0.44
HTR2C P28335 6/20 0.40
CRBN Q96SW2 4/20 0.38
ALDH1A1 P00352 4/20 0.36
KDM4E B2RXH2 2/20 0.36
MAPT P10636 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HTR2A P28223 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
DDB1 Q16531 2/20 0.35
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.35
CA9 Q16790 1/20 0.34
RAB9A P51151 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3602346 0.89 CA9 (0.43) DRD2DRD4HTR2CCRBNALDH1A1
SCHEMBL3594463 0.89 DRD2 (0.45) DRD2DRD4CRBNALDH1A1KDM4E
SCHEMBL3580791 0.88 TSHR (0.46) DRD2DRD4CRBNALDH1A1KDM4E
SCHEMBL3596528 0.86 DRD2 (0.46) DRD2DRD4CRBNALDH1A1KDM4E
SCHEMBL3602300 0.86 DRD2 (0.44) DRD2DRD4CRBNALDH1A1KDM4E
SCHEMBL3606191 0.85 DRD2 (0.43) DRD2DRD4CRBNALDH1A1KDM4E
SCHEMBL3602000 0.85 DRD2 (0.43) DRD2DRD4CRBNALDH1A1MAPT
SCHEMBL3595292 0.84 DRD2 (0.42) DRD2DRD4CRBNALDH1A1KDM4E
SCHEMBL3604336 0.84 DRD2 (0.42) DRD2DRD4CRBNALDH1A1KDM4E
SCHEMBL4457511 0.84 DRD2 (0.44) DRD2DRD4HTR2CALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2128157-A1 HETEROCYCLIDENE-N-(ARYL)ACETAMIDE DERIVATIVE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2009-12-02 EP disclosed